The mental illness "franchise" has been very good to Pharma. While it could not "grow" the number of people with actual schizophrenia, it has successfully grown those diagnosed with amorphous "schizoaffective" and bipolar disorders and, of course, depression.
Thanks to Pharma’s everyone-is-mentally-ill ploy, buoyed by the Pharma-funded writers of the Diagnostic and Statistical Manual of Mental Disorders, an estimated one quarter of the population now takes psych drugs. Gone are the days when bad moods were attributed to problems with finance, romance, jobs, housing, family, marriages and health.